Download presentation
Presentation is loading. Please wait.
1
Volume 62, Pages S36-S41 (December 2002)
Angiotensin II type 1 receptor blockade to control blood pressure in postmenopausal women: Influence of hormone replacement therapy Francisco Fernández-Vega, José Abellán, Onofre Vegazo, Soledad García De Vinuesa, José Carlos Rodríguez, Benito Maceira, Saturnino Sanz De Castro, Roberto Robles Nicolás, José Luño Kidney International Volume 62, Pages S36-S41 (December 2002) DOI: /j s82.8.x Copyright © 2002 International Society of Nephrology Terms and Conditions
2
Figure 1 Course of the mean (A) systolic and (B) diastolic blood pressure (SBP and DBP) values on the different follow-up visits of the study. (C) Time course of the mean percentage SBP (♦) and DBP (▪) control values and global BP (▴) control (SBP ≤140 mm Hg and/or DBP ≤90 mm Hg) in the course of the 24 weeks of follow-up (means ± standard deviation, SD). *P < 0.01, †P < 0.01 vs. Visit 1 and Visit 2. Kidney International , S36-S41DOI: ( /j s82.8.x) Copyright © 2002 International Society of Nephrology Terms and Conditions
3
Figure 2 Time course of the mean global percentage BP control (A, SBP ≤140 mm Hg and/orB, DBP ≤90 mm Hg) throughout the 24 weeks of follow-up of the study, in the subgroups of patients with and without hormone replacement therapy (HRT). Data are means ± standard deviation (SD). Symbols are: (♦) with hydrochlorothiazide (HCTZ), N = 122; (▪) without HCTZ, N = 265. *P < 0.01 in both subgroups. In (C), the odds ratio = 1.8, 95% CI = , and P < 0.03. Kidney International , S36-S41DOI: ( /j s82.8.x) Copyright © 2002 International Society of Nephrology Terms and Conditions
4
Figure 3 Blood pressure control in postmenopausal women with HRT (•) or without HRT (▪) during successive visits. Kidney International , S36-S41DOI: ( /j s82.8.x) Copyright © 2002 International Society of Nephrology Terms and Conditions
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.